LYON, France, March 12, 2019 (GLOBE NEWSWIRE) --
Article 223-16 of general regulation of French Autorité des Marchés Financiers
Lyon - France
Euronext Paris from Euronext (Market segment C - ISIN Code: FR0011471135- Symbol: ERYP) &
Nasdaq Global Select Market in the United-States (ERYP.PA)
Website : www.erytech.com
|Date||Total of shares composing |
the share capital
|Total of brut(1) voting |
| Total of net(2) voting |
|December 31, 2018||17 940 035||19 525 606||19 523 106|
|January 31, 2019||17 940 035||19 525 918||19 523 418|
|February 28, 2019||17 940 035||19 525 792||19 523 292|
(1) Gross voting rights number (or « theoretical » voting rights) is used as a basis for calculating the crossing of the threshold. In accordance with article 223-11 of general regulation of Autorité des Marchés Financiers, this number is calculated on the basis of all shares carrying the single and double voting rights, including shares without voting rights.
(2) Without treasury shares.
This announcement is distributed by West Corporation on behalf of West Corporation clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Erytech Pharma S.A. via GlobeNewswire